Interestingly, even though TP53 somatic mutations are generally more common in ER- tumours, the increased prevalence of TP53 somatic mutations in Asian women relative to Caucasian women appears to be more pronounced in ER + tumours [2]. This evidence concerns the gene TP53 and neoplasm.